Tuberculosis

Print

altThe Tuberculosis Programme Area Component contributes to the reduction of the Tuberculosis (TB) disease burden in the WHO Africa Region through support to all member states to adopt and implement cost-effective TB prevention, treatment, care and support interventions.


Feature

What is multidrug-resistant tuberculosis and how do we control it?

Online Q&A

Q: What is multidrug-resistant tuberculosis and how do we control it?

A: The bacteria that cause tuberculosis (TB) can develop resistance to the antimicrobial drugs used to cure the disease. Multidrug-resistant tuberculosis (MDR-TB) is TB that does not respond to at least isoniazid and rifampicin, the two most powerful anti-TB drugs.

read more in the multidrug-resistant tuberculosis Q&A